Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease

C. Falcone, P. Minoretti, A. D'Angelo, M. P. Buzzi, E. Coen, E. Emanuele, A. Aldeghi, V. Olivieri, D. Geroldi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: The eotaxin family comprises three distinct peptides (eotaxin, eotaxin-2 and eotaxin-3) which have been implicated in eosinophilic inflammation. In vitro and clinical studies suggest that eotaxins could play a role in vascular inflammation, but no data are available on their prognostic significance in patients with angiographically documented coronary artery disease (CAD). Materials and methods: Baseline plasma samples were obtained from 1014 patients with documented CAD. We tested the predictive effect of markers of eosinophilic inflammation and C-reactive protein (CRP) on death from cardiovascular causes and nonfatal myocardial infarction over a 2.7-4.1-year follow-up period. Results: Unexpectedly, lower eotaxin-3 concentrations were observed in patients with adverse cardiovascular events, whereas both eotaxin and eotaxin-2 showed no association with risk. After adjustment for most potential confounders, patients in the upper-quartile of eotaxin-3 levels had a 0.42 hazard-ratio (95% CI, 0.29-0.61, P <0.001) for adverse events compared with subjects in the lower-quartile. The highest risk of future cardiovascular events was observed in subjects with combined elevation of CRP and reduction of eotaxin-3; 4.4 hazard-ratio (95% CI, 2.1-9.5, P <0.001). Importantly, receiver-operating-characteristic curves analysis suggested a superior prognostic value of eotaxin-3 compared with CRP for predicting cardiac events in patients with CAD. Conclusions: Low levels of eotaxin-3 are an independent predictor of future adverse cardiovascular events in patients with CAD and may be useful for risk stratification.

Original languageEnglish
Pages (from-to)211-217
Number of pages7
JournalEuropean Journal of Clinical Investigation
Volume36
Issue number4
DOIs
Publication statusPublished - Apr 2006

Fingerprint

Coronary Artery Disease
Chemokine CCL24
C-Reactive Protein
Inflammation
Hazards
Association reactions
Plasmas
ROC Curve
Peptides
Blood Vessels
Cause of Death
Myocardial Infarction

Keywords

  • Coronary artery disease
  • Cytokines
  • Outcome
  • Risk factors

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease. / Falcone, C.; Minoretti, P.; D'Angelo, A.; Buzzi, M. P.; Coen, E.; Emanuele, E.; Aldeghi, A.; Olivieri, V.; Geroldi, D.

In: European Journal of Clinical Investigation, Vol. 36, No. 4, 04.2006, p. 211-217.

Research output: Contribution to journalArticle

Falcone, C, Minoretti, P, D'Angelo, A, Buzzi, MP, Coen, E, Emanuele, E, Aldeghi, A, Olivieri, V & Geroldi, D 2006, 'Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease', European Journal of Clinical Investigation, vol. 36, no. 4, pp. 211-217. https://doi.org/10.1111/j.1365-2362.2006.01624.x
Falcone, C. ; Minoretti, P. ; D'Angelo, A. ; Buzzi, M. P. ; Coen, E. ; Emanuele, E. ; Aldeghi, A. ; Olivieri, V. ; Geroldi, D. / Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease. In: European Journal of Clinical Investigation. 2006 ; Vol. 36, No. 4. pp. 211-217.
@article{7bbaa104dc474975a261af521c8c97a9,
title = "Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease",
abstract = "Background: The eotaxin family comprises three distinct peptides (eotaxin, eotaxin-2 and eotaxin-3) which have been implicated in eosinophilic inflammation. In vitro and clinical studies suggest that eotaxins could play a role in vascular inflammation, but no data are available on their prognostic significance in patients with angiographically documented coronary artery disease (CAD). Materials and methods: Baseline plasma samples were obtained from 1014 patients with documented CAD. We tested the predictive effect of markers of eosinophilic inflammation and C-reactive protein (CRP) on death from cardiovascular causes and nonfatal myocardial infarction over a 2.7-4.1-year follow-up period. Results: Unexpectedly, lower eotaxin-3 concentrations were observed in patients with adverse cardiovascular events, whereas both eotaxin and eotaxin-2 showed no association with risk. After adjustment for most potential confounders, patients in the upper-quartile of eotaxin-3 levels had a 0.42 hazard-ratio (95{\%} CI, 0.29-0.61, P <0.001) for adverse events compared with subjects in the lower-quartile. The highest risk of future cardiovascular events was observed in subjects with combined elevation of CRP and reduction of eotaxin-3; 4.4 hazard-ratio (95{\%} CI, 2.1-9.5, P <0.001). Importantly, receiver-operating-characteristic curves analysis suggested a superior prognostic value of eotaxin-3 compared with CRP for predicting cardiac events in patients with CAD. Conclusions: Low levels of eotaxin-3 are an independent predictor of future adverse cardiovascular events in patients with CAD and may be useful for risk stratification.",
keywords = "Coronary artery disease, Cytokines, Outcome, Risk factors",
author = "C. Falcone and P. Minoretti and A. D'Angelo and Buzzi, {M. P.} and E. Coen and E. Emanuele and A. Aldeghi and V. Olivieri and D. Geroldi",
year = "2006",
month = "4",
doi = "10.1111/j.1365-2362.2006.01624.x",
language = "English",
volume = "36",
pages = "211--217",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease

AU - Falcone, C.

AU - Minoretti, P.

AU - D'Angelo, A.

AU - Buzzi, M. P.

AU - Coen, E.

AU - Emanuele, E.

AU - Aldeghi, A.

AU - Olivieri, V.

AU - Geroldi, D.

PY - 2006/4

Y1 - 2006/4

N2 - Background: The eotaxin family comprises three distinct peptides (eotaxin, eotaxin-2 and eotaxin-3) which have been implicated in eosinophilic inflammation. In vitro and clinical studies suggest that eotaxins could play a role in vascular inflammation, but no data are available on their prognostic significance in patients with angiographically documented coronary artery disease (CAD). Materials and methods: Baseline plasma samples were obtained from 1014 patients with documented CAD. We tested the predictive effect of markers of eosinophilic inflammation and C-reactive protein (CRP) on death from cardiovascular causes and nonfatal myocardial infarction over a 2.7-4.1-year follow-up period. Results: Unexpectedly, lower eotaxin-3 concentrations were observed in patients with adverse cardiovascular events, whereas both eotaxin and eotaxin-2 showed no association with risk. After adjustment for most potential confounders, patients in the upper-quartile of eotaxin-3 levels had a 0.42 hazard-ratio (95% CI, 0.29-0.61, P <0.001) for adverse events compared with subjects in the lower-quartile. The highest risk of future cardiovascular events was observed in subjects with combined elevation of CRP and reduction of eotaxin-3; 4.4 hazard-ratio (95% CI, 2.1-9.5, P <0.001). Importantly, receiver-operating-characteristic curves analysis suggested a superior prognostic value of eotaxin-3 compared with CRP for predicting cardiac events in patients with CAD. Conclusions: Low levels of eotaxin-3 are an independent predictor of future adverse cardiovascular events in patients with CAD and may be useful for risk stratification.

AB - Background: The eotaxin family comprises three distinct peptides (eotaxin, eotaxin-2 and eotaxin-3) which have been implicated in eosinophilic inflammation. In vitro and clinical studies suggest that eotaxins could play a role in vascular inflammation, but no data are available on their prognostic significance in patients with angiographically documented coronary artery disease (CAD). Materials and methods: Baseline plasma samples were obtained from 1014 patients with documented CAD. We tested the predictive effect of markers of eosinophilic inflammation and C-reactive protein (CRP) on death from cardiovascular causes and nonfatal myocardial infarction over a 2.7-4.1-year follow-up period. Results: Unexpectedly, lower eotaxin-3 concentrations were observed in patients with adverse cardiovascular events, whereas both eotaxin and eotaxin-2 showed no association with risk. After adjustment for most potential confounders, patients in the upper-quartile of eotaxin-3 levels had a 0.42 hazard-ratio (95% CI, 0.29-0.61, P <0.001) for adverse events compared with subjects in the lower-quartile. The highest risk of future cardiovascular events was observed in subjects with combined elevation of CRP and reduction of eotaxin-3; 4.4 hazard-ratio (95% CI, 2.1-9.5, P <0.001). Importantly, receiver-operating-characteristic curves analysis suggested a superior prognostic value of eotaxin-3 compared with CRP for predicting cardiac events in patients with CAD. Conclusions: Low levels of eotaxin-3 are an independent predictor of future adverse cardiovascular events in patients with CAD and may be useful for risk stratification.

KW - Coronary artery disease

KW - Cytokines

KW - Outcome

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=33645279833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645279833&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2362.2006.01624.x

DO - 10.1111/j.1365-2362.2006.01624.x

M3 - Article

C2 - 16620281

AN - SCOPUS:33645279833

VL - 36

SP - 211

EP - 217

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 4

ER -